This article was originally published in The Gray Sheet
Firm's INRange monitored heart valve system commences clinical trials to evaluate use in patient self-testing and telephone monitoring of anticoagulation medication. INRange incorporates the CPHV Carbomedics prosthetic heart valve, a prothrombin time measuring device, and telephone monitoring services by Raytel Cardiac Services
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.